Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	33
Overall Study	STARTED	AEGR-733 2.5 mg	34
Overall Study	STARTED	AEGR-733 5 mg	34
Overall Study	STARTED	AEGR-733 7.5 mg	34
Overall Study	STARTED	AEGR-733 10 mg	35
Overall Study	STARTED	AEGR-733 5 mg + Atorvastatin 20 mg	28
Overall Study	STARTED	AEGR-733 5 mg + Fenofibrate 145 mg	33
Overall Study	STARTED	AEGR-733 5 mg + Ezetimibe 10 mg	29
Overall Study	COMPLETED	Placebo	31
Overall Study	COMPLETED	AEGR-733 2.5 mg	25
Overall Study	COMPLETED	AEGR-733 5 mg	24
Overall Study	COMPLETED	AEGR-733 7.5 mg	29
Overall Study	COMPLETED	AEGR-733 10 mg	21
Overall Study	COMPLETED	AEGR-733 5 mg + Atorvastatin 20 mg	23
Overall Study	COMPLETED	AEGR-733 5 mg + Fenofibrate 145 mg	28
Overall Study	COMPLETED	AEGR-733 5 mg + Ezetimibe 10 mg	25
Overall Study	NOT COMPLETED	Placebo	2
Overall Study	NOT COMPLETED	AEGR-733 2.5 mg	9
Overall Study	NOT COMPLETED	AEGR-733 5 mg	10
Overall Study	NOT COMPLETED	AEGR-733 7.5 mg	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00559962/flow